{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:25:07Z","timestamp":1790601907150,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05473-9","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T04:18:54Z","timestamp":1752466734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022"],"prefix":"10.1186","volume":"24","author":[{"given":"Abel","family":"Nhama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlindo","family":"Chidimatembue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia","family":"Nhamussua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e9nio","family":"Nhacolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Arnaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crizolgo","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Cassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Candrinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9rcia","family":"Dimene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abuchahama","family":"Saifodine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Wate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio","family":"Mucavele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaritbel","family":"Torres-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Plucinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Cistero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"5473_CR1","first-page":"2024","volume-title":"Addressing inequity in the global malaria response","author":"WHO. World malaria report","year":"2024","unstructured":"WHO. World malaria report. Addressing inequity in the global malaria response. Geneva: World Health Organization; 2024. p. 2024."},{"key":"5473_CR2","unstructured":"Instituto Nacional de Sa\u00fade (INS) e ICF. Inqu\u00e9rito Nacional sobre Indicadores de Mal\u00e1ria em Mo\u00e7ambique 2018. Maputo, Mo\u00e7ambique. Rockville, Maryland, EUA: INS e ICF.; 2019."},{"key":"5473_CR3","unstructured":"Inst\u00edtuto Nacional de Estat\u00edstica (INE) e ICF. Inqu\u00e9rito Demogr\u00e1fico e de Sa\u00fade, 2022\u201323. Maputo, Mo\u00e7ambique. Rockville, Maryland, EUA: INS e ICF.; 2024."},{"key":"5473_CR4","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"5473_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"5473_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMc0900231","volume":"361","author":"H Noedl","year":"2009","unstructured":"Noedl H, Socheat D, Satimai W. Artemisinin-resistant malaria in Asia. N Engl J Med. 2009;361:540\u20131.","journal-title":"N Engl J Med"},{"key":"5473_CR7","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1128\/AAC.00835-15","volume":"59","author":"R Leang","year":"2015","unstructured":"Leang R, Taylor WRJ, Bouth DM, Song L, Tarning J, Char MC, et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: Dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrob Agents Chemother. 2015;59:4719\u201326.","journal-title":"Antimicrob Agents Chemother"},{"key":"5473_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"5473_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana S-I, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"5473_CR10","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120\u20138.","journal-title":"Lancet Infect Dis"},{"key":"5473_CR11","unstructured":"MISAU\/Programa Nacional de Controlo da mal\u00e1ria. NORMAS DE MANEJO DOS CASOS DE MAL\u00c1RIA EM MO\u00c7AMBIQUE [Internet]. Maputo; 2005. Available from: https:\/\/www.saudedirecta.com.docsupload\/1332096.normas_malaria.pdf"},{"key":"5473_CR12","unstructured":"MISAU\/DNSP\/PNCM. Normas deTratamento da Mal\u00e1ria em Mo\u00e7ambique [Internet]. Maputo; 2017. Available from: https:\/\/platform.who.int\/docs\/default-source\/mca-documents\/policy-documents\/guideline\/MOZ-CH-33-01-GUIDELINE-2017-prt-Normas-Tratamento-Malaria.pdf"},{"key":"5473_CR13","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(08)61492-0","volume":"372","author":"S Abdulla","year":"2008","unstructured":"Abdulla S, Sagara I, Borrmann S, D\u2019Alessandro U, Gonzalez R, Hamel M, et al. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet. 2008;372:1819\u201327.","journal-title":"Lancet"},{"key":"5473_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007871","volume":"4","author":"Q Bassat","year":"2009","unstructured":"Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Nabasumba C, et al. Dihydroartemisin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS ONE. 2009;4: e7871.","journal-title":"PLoS ONE"},{"key":"5473_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1475-2875-10-369","volume":"10","author":"Q Bassat","year":"2011","unstructured":"Bassat Q, Gonzalez R, Machevo S, Nahum A, Lyimo J, Maiga H, et al. Similar efficacy and safety of artemether-lumefantrine (Coartem(R)) in African infants and children with uncomplicated falciparum malaria across different body weight ranges. Malar J. 2011;10:369.","journal-title":"Malar J"},{"key":"5473_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/1475-2875-13-309","volume":"13","author":"A Nhama","year":"2014","unstructured":"Nhama A, Bassat Q, Enosse S, Nhacolo A, Mutemba R, Carvalho E, et al. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique. Malar J. 2014;13:309.","journal-title":"Malar J"},{"key":"5473_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.actatropica.2017.03.032","volume":"171","author":"C Salvador","year":"2017","unstructured":"Salvador C, Rafael B, Matsinhe F, Candrinho B, Muthemba R, De CE, et al. Efficacy and safety of artemether\u2013lumefantrine for the treatment of uncomplicated falciparum malaria at sentinel sites in Mozambique, 2015. Acta Trop. 2017;171:146\u201350.","journal-title":"Acta Trop"},{"key":"5473_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12936-021-03922-9","volume":"20","author":"A Nhama","year":"2021","unstructured":"Nhama A, Nham\u00fassua L, Macete E, Bassat Q, Salvador C, Enosse S, et al. In vivo efficacy and safety of artemether\u2013lumefantrine and amodiaquine\u2013artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018. Malar J. 2021;20:390.","journal-title":"Malar J"},{"key":"5473_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003227","volume":"17","author":"B Galatas","year":"2020","unstructured":"Galatas B, Sa\u00fate F, Mart\u00ed-Soler H, Guinovart C, Nhamussua L, Simone W, et al. A multiphase program for malaria elimination in southern Mozambique (the Magude project): a before-after study. PLoS Med. 2020;17: e1003227.","journal-title":"PLoS Med"},{"key":"5473_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12936-021-03930-9","volume":"20","author":"A Chidimatembue","year":"2021","unstructured":"Chidimatembue A, Svigel SS, Mayor A, A\u00edde P, Nhama A, Nhamussua L, et al. Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018. Malar J. 2021;20:398.","journal-title":"Malar J"},{"key":"5473_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s42003-023-04997-7","volume":"6","author":"C Silva","year":"2023","unstructured":"Silva C, Boene S, Datta D, Rovira-vallbona E, Aranda-d\u00edaz A, Cister\u00f3 P, et al. Targeted and whole-genome sequencing reveal a north-south divide in P. falciparum drug resistance markers and genetic structure in Mozambique. Commun Biol. 2023;6:619.","journal-title":"Commun Biol."},{"key":"5473_CR22","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy [Internet]. Geneva; World Health Organization, 2009 [cited 2025 Jun 3]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44048\/9789241597531_eng.pdf"},{"key":"5473_CR23","doi-asserted-by":"crossref","unstructured":"WHO. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94 Suppl 1:S1\u201390.","DOI":"10.1016\/S0035-9203(00)90300-6"},{"key":"5473_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12936-015-0664-9","volume":"14","author":"R Baiden","year":"2015","unstructured":"Baiden R, Oduro A, Halidou T, Gyapong M, Sie A, Macete E, et al. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim\u00ae (dihydroartemisinin\/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania. Malar J. 2015;14:160.","journal-title":"Malar J"},{"key":"5473_CR25","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(10)60322-4","volume":"375","author":"AK Tshefu","year":"2010","unstructured":"Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SSS, et al. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet. 2010;375:1457\u201367.","journal-title":"Lancet"},{"key":"5473_CR26","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd edn. Geneva, World Health Organization, 2015."},{"key":"5473_CR27","unstructured":"WHO. Malaria parasite counting [Internet]. Geneva; World Health Organization, 2016. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/340469\/WHO-HTM-GMP-MM-SOP-2016.09-eng.pdf"},{"key":"5473_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4269\/ajtmh.2005.73.191","volume":"73","author":"L Andrews","year":"2005","unstructured":"Andrews L, Andersen RF, Webster D, Dunachie S, Walther RM, Bejon P, et al. Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials. Am J Trop Med Hyg. 2005;73:191\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5473_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1475-2875-8-78","volume":"8","author":"A Liljander","year":"2009","unstructured":"Liljander A, Wiklund L, Falk N, Kweku M, Mrtensson A, Felger I, et al. Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2). Malar J. 2009;8:78.","journal-title":"Malar J"},{"key":"5473_CR30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/oxfordjournals.molbev.a026247","volume":"17","author":"TJC Anderson","year":"2000","unstructured":"Anderson TJC, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, et al. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol. 2000;17:1467\u201382.","journal-title":"Mol Biol Evol"},{"key":"5473_CR31","unstructured":"WHO. Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas. Report of a virtual meeting, 17\u201318 May 2021. Geneva, World Health Organization, 2021."},{"key":"5473_CR32","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.pt.2022.08.005","volume":"38","author":"IM Hastings","year":"2022","unstructured":"Hastings IM, Felger I. WHO antimalarial trial guidelines: Good science, bad news? Trends Parasitol. 2022;38:933\u201341.","journal-title":"Trends Parasitol"},{"key":"5473_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"5473_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95: 103208.","journal-title":"J Biomed Inform"},{"key":"5473_CR35","unstructured":"R Core Team. A Language and Environment for Statistical Computing. Vienna, Austria; 2024."},{"key":"5473_CR36","unstructured":"WHO. Multiple first-line therapies as part of the response to antimalarial drug resistance: an implementation guide [Internet]. Geneva; World Health Organization, 2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240103603."},{"key":"5473_CR37","unstructured":"WHO. Guidelines for malaria, 16 October 2023. Geneva; World Health Organization, 2023."},{"key":"5473_CR38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1475-2875-8-200","volume":"8","author":"K Stepniewska","year":"2009","unstructured":"Stepniewska K, Taylor W, Sirima SB, Ouedraogo EB, Ouedraogo A, Gansan\u00e9 A, et al. Population pharmacokinetics of artesunate and amodiaquine in African children. Malar J. 2009;8:200.","journal-title":"Malar J"},{"key":"5473_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2125.2004.02257.x","volume":"59","author":"FW Hombhanje","year":"2005","unstructured":"Hombhanje FW, Hwaihwanje I, Tsukahara T, Saruwatari J, Nakagawa M, Osawa H, et al. The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria. Br J Clin Pharmacol. 2005;59:298\u2013301.","journal-title":"Br J Clin Pharmacol"},{"key":"5473_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00260-18","volume":"62","author":"H Liu","year":"2018","unstructured":"Liu H, Zhou H, Cai T, Yang A, Zang M, Xing J. Metabolism of piperaquine to its antiplasmodial metabolites and their pharmacokinetic profiles in healthy volunteers. Antimicrob Agents Chemother. 2018;62:1\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"5473_CR41","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/jac\/dkad260","volume":"78","author":"WY Chu","year":"2023","unstructured":"Chu WY, Dorlo TPC. Pyronaridine: a review of its clinical pharmacology in the treatment of malaria. J Antimicrob Chemother. 2023;78:2406\u201318.","journal-title":"J Antimicrob Chemother"},{"key":"5473_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/1475-2875-12-235","volume":"12","author":"EM Staehli Hodel","year":"2013","unstructured":"Staehli Hodel EM, Guidi M, Zanolari B, Mercier T, Duong S, Kabanywanyi AM, et al. Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients. Malar J. 2013;12:235.","journal-title":"Malar J"},{"key":"5473_CR43","unstructured":"WHO. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). Geneva. World Health Organization; 2020."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05473-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05473-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05473-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:45:50Z","timestamp":1757231150000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05473-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5473"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05473-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical trial protocol has been cleared and approved by the National Bioethics Committee (Comit\u00e9 Nacional de Bio\u00e9tica para a Sa\u00fade de Mo\u00e7ambique (CNBS\u2014IRB00002657)). The parents or guardians have given written informed consent before the participants\u2019 enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}